Patents by Inventor Vikash Kumar Dubey

Vikash Kumar Dubey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8153770
    Abstract: Mutants of human FGF-1 are disclosed having increased stability and mitogenic potency. In the FGF-1 polypeptide, primarily residue 12 is substituted with cysteine and/or residue 134 is substituted cysteine, valine or threonine to render the polypeptide more stable and/or to increase its mitogenecity.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: April 10, 2012
    Assignee: Florida State University Research Foundation, Inc.
    Inventors: Michael Blaber, Vikash Kumar Dubey
  • Patent number: 8153771
    Abstract: Mutants of human FGF-1 are disclosed having increased stability and mitogenic potency. In the FGF-1 polypeptide, primarily residue 12 is substituted with threonine and/or residue 134 is substituted cysteine, valine or threonine to render the polypeptide more stable and/or to increase its mitogenecity.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: April 10, 2012
    Assignee: Florida State University Research Foundation, Inc.
    Inventors: Michael Blaber, Vikash Kumar Dubey
  • Patent number: 8119776
    Abstract: Mutants of human FGF-1 are disclosed having increased stability and mitogenic potency. In the FGF-1 polypeptide, primarily residue 12 is substituted with valine and residue 134 is substituted cysteine or threonine to render the polypeptide more stable and/or to increase its mitogenecity.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: February 21, 2012
    Assignee: Florida State University Research Foundation, Inc.
    Inventors: Michael Blaber, Vikash Kumar Dubey
  • Patent number: 7776825
    Abstract: The ?-trefoil protein human fibroblast growth factor-1 (FGF-1) is made up of a six-stranded anti-parallel ?-barrel closed off on one end by three ?-hairpins, thus exhibiting a three-fold axis of structural symmetry. The N- and C-termini ?-strands hydrogen bond to each other and are postulated from both NMR and X-ray structure data to represent a structurally-weakened region of the ?-barrel. Val mutations within the N- and C-termini ?-strands are shown to stabilize the structure and to increase van der Waals contacts by filling local cavities present within this region. Mutations that increase van der Waals contacts between both the N- and C-termini ?-strands are generally associated with significant reductions in the unfolding kinetics, and also increase the cooperativity of unfolding. Surprisingly, several mutant polypeptides herein disclosed greatly exceed the wild-type polypeptide in ability to stimulate human fibroblasts to proliferate.
    Type: Grant
    Filed: November 7, 2007
    Date of Patent: August 17, 2010
    Assignee: Florida State University Research Foundation, Incorporated
    Inventors: Michael Blaber, Vikash Kumar Dubey
  • Patent number: 7696171
    Abstract: The ?-trefoil protein human fibroblast growth factor-1 (FGF-1) is made up of a six-stranded anti-parallel ?-barrel closed off on one end by three ?-hairpins, thus exhibiting a three-fold axis of structural symmetry. The N- and C-termini ?-strands hydrogen bond to each other and are postulated from both NMR and X-ray structure data to represent a structurally-weakened region of the ?-barrel. Val mutations within the N- and C-termini ?-strands are shown to stabilize the structure and to increase van der Waals contacts by filling local cavities present within this region. Mutations that increase van der Waals contacts between both the N- and C-termini ?-strands are generally associated with significant reductions in the unfolding kinetics, and also increase the cooperativity of unfolding. Surprisingly, several mutant polypeptides herein disclosed greatly exceed the wild-type polypeptide in ability to stimulate human fibroblasts to proliferate.
    Type: Grant
    Filed: November 7, 2007
    Date of Patent: April 13, 2010
    Assignee: The Florida State University Research Foundation, Inc.
    Inventors: Michael Blaber, Vikash Kumar Dubey
  • Patent number: 7659379
    Abstract: Mutants of human FGF-1 are disclosed having increased stability and mitogenic potency. In the FGF-1 polypeptide, primarily residues 12 and 134 are substituted with cysteine, valine or threonine to render the polypeptide more stable and/or to increase its mitogenicity.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: February 9, 2010
    Assignee: Florida State University Research Foundation, Inc.
    Inventors: Michael Blaber, Vikash Kumar Dubey